Back to results
US 2017/0283403 A1Published application
Diamide macrocycles that are fxia inhibitors
AssigneeBristol-Myers Squibb Company
InventorsJun Shi, William R. Ewing, Laura Nielsen, Zilun HU, Mimi L. Quan
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds of Formula (I) or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective Factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
Claims13
A compound of Formula (I):
- or a stereoisomer, a tautomer, a pharmaceutically acceptable salt thereof, wherein:
- is an optional bond;
- ring A is independently selected from a C3-10 carbocycle and a 5- to 10-membered heterocycle comprising:
- carbon atoms and 1-4 heteroatoms selected from N, NH, N(C1-4 alkyl), NC(═NH)NH2, O, and S;
- ring B is independently selected from a aryl and a 5- to 10-membered heterocycle;
- L1 is independently selected from a
- bond, —CR5R5—, —CHR5CHR5—, —CR5═CR5—, —C≡C—, —OCH2—, —CHR5NH—, —CH2O—, —SCH2—, —SO2CH2—, and —CH2NH—;
- R1 is, independently at each occurrence, selected from halogen, C1-6 alkyl, C1-4 alkoxy, C1-4 alkylthio, C1-4 haloalkyl, OH, ═O, OCH2F, OCHF2, OCF3, CF3, CN, NH2, NH(C1-4 alkyl), N(C1-4 alkyl)2, CO2(C1-4 alkyl), CO(C1-4 alkyl), —CH2NH2, —CONH2, —CONH(C1-4 alkyl), —OCH2CO2H, —NHCO(C1-4 alkyl), —NHCO2(C1-4 alkyl), —NHSO2(C1-4 alkyl), —SO2NH2, and —C(═NH)NH2;
- R2 is a 5- to 7-membered heterocycle comprising carbon atoms and 1-4 heteroatoms selected from N, NH, N(C1-4 alkyl), O, and S(O)2, wherein said heterocycle is substituted with 0-2 R2a;
- R2a is, independently at each occurrence, selected from halogen, C1-4 alkyl, —CH2OH, C1-4 alkoxy, OH, CF3, OCF3, OCH2F, OCHF2, CN, NH2, CO2H, CO2(C1-4 alkyl), COC1-4 alkyl, —CONH2, —CONH(C1-4 alkyl), —CON(C1-4 alkyl)2, —SO2(C1-4 alkyl), —SO2NH2, —SO2NH(C1-4 alkyl), and —SO2N(C1-4 alkyl)2;
- R3 is independently selected from H and C1-4 alkyl;
- alternatively, L1 and R3, together with the nitrogen atom to which they are attached, form a ring;
- R4 is selected from H, C1-4 alkyl, hydroxyl, F, CF3, and C3-6 cycloalkyl;
- R5 is selected from H and C1-4 alkyl;
- R6 is selected from H, halogen, C(O)OH, and C(O)O(C1-4 alkyl);
- R7 is selected from H, C1-4 alkyl, and CF3;
- alternatively, R6 and R7 together are ═O;
- and
- R8 is, independently at each occurrence, selected from H, halogen, NHCO2C1-4 alkyl, CN, OH, O—C1-4 alkyl, CF3, —OCF3, —OCHF2, —CHF2, —CH2F, CO2H, CO2(C1-4 alkyl), —CH2CO2H, —(CH2)2CO2H, —CH2CO2(C1-4 alkyl), —(CH2)2CO2(C1-4 alkyl), NH2, —CH2NH2, —NHCO(C1-4 alkyl), —NHCO2(CH2)1-2O(C1-4 alkyl), —NHCO2(CH2)1-3O(C1-4 alkyl), NHCO2CH2CH(C1-4 alkyl)O(C1-4 alkyl), —NHCO2(CH2)1-2OH, —NHCO2CH2CO2H, —CH2NHCO2(C1-4 alkyl), —NHC(O)NH(C1-4 alkyl), —NHC(O)N(C1-4 alkyl)2, NHC(O)NH(C1-4 alkyl)N(5- to 6-membered heterocycle), —NHSO2(C1-4 alkyl), —CONH2, —CONH(C1-4 alkyl), —CON(C1-4 alkyl)2, and —CH2CONH2.
16 more elements
(canceled)
Dependencies are inferred from the claim text.